|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| CURRENT ASSETS: | |||||
| Cash and cash equivalents | |||||
| Marketable securities | |||||
| Accounts receivable - net of allowance for credit losses of $889 and $296 as of December 31, 2025 and 2024, respectively | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Property and equipment, net | |||||
| Operating lease right-of-use assets | |||||
| Deferred tax assets, net | |||||
| Other long-term assets | |||||
| Total long-term assets | |||||
| Total assets | |||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||
| CURRENT LIABILITIES: | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities, current | |||||
| Total current liabilities | |||||
| Operating lease liabilities, non-current | |||||
| Deferred revenue, non-current | |||||
| Total long-term liabilities | |||||
| Total liabilities | |||||
| SHAREHOLDERS’ EQUITY: | |||||
| Ordinary shares, no par value - Authorized: 99,999,999 as of December 31, 2025, and 2024; Issued and Outstanding:51,160,822 and 50,773,337 as of December 31, 2025 and 2024, respectively | |||||
| Founders’ shares, no par value: Authorized: 1 share as of December 31, 2025, and 2024; Issued and Outstanding: 1 share as of December 31, 2025 and 2024 | |||||
| Additional paid-in capital | |||||
| Accumulated other comprehensive income | |||||
| Accumulated deficit | |||||
| Total shareholders’ equity | |||||
| Total liabilities, and shareholders’ equity |
Loading...